Epstein-Barr virus-related lymphoproliferative disease after allogeneic bone marrow transplantation for severe aplastic anemia complicated by the syndrome of inappropriate secretion of antidiuretic hormone.
Ostronoff
M
M
Ostronoff
F
F
Florêncio
R
R
Maior
A P Souto
AP
Sucupira
A
A
Calixto
R
R
Domingues
M C
MC
Tagliari
C
C
D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004317:Doxorubicin / Q000008:administration & dosage; D020031:Epstein-Barr Virus Infections / Q000150:complications*; D005260:Female; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000150:complications* / Q000188:drug therapy; D008232:Lymphoproliferative Disorders / Q000188:drug therapy / Q000209:etiology*; D000069283:Rituximab; D014184:Transplantation, Homologous / Q000009:adverse effects
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D004317:Doxorubicin